BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20086245)

  • 1. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
    Zhao JJ; Lin J; Lwin T; Yang H; Guo J; Kong W; Dessureault S; Moscinski LC; Rezania D; Dalton WS; Sotomayor E; Tao J; Cheng JQ
    Blood; 2010 Apr; 115(13):2630-9. PubMed ID: 20086245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.
    Iqbal J; Shen Y; Liu Y; Fu K; Jaffe ES; Liu C; Liu Z; Lachel CM; Deffenbacher K; Greiner TC; Vose JM; Bhagavathi S; Staudt LM; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Gascoyne RD; Armitage JO; Weisenburger DD; McKeithan TW; Chan WC
    Blood; 2012 May; 119(21):4939-48. PubMed ID: 22490335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
    Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
    Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle cell lymphoma: transcriptional regulation by microRNAs.
    Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
    Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
    Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
    J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
    Husby S; Ralfkiaer U; Garde C; Zandi R; Ek S; Kolstad A; Jerkeman M; Laurell A; Räty R; Pedersen LB; Pedersen A; Ehinger M; Sundström C; Karjalainen-Lindsberg ML; Delabie J; Clasen-Linde E; Brown P; Cowland JB; Workman CT; Geisler CH; Grønbæk K
    Blood; 2015 Apr; 125(17):2669-77. PubMed ID: 25736311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.
    Navarro A; Clot G; Prieto M; Royo C; Vegliante MC; Amador V; Hartmann E; Salaverria I; Beà S; Martín-Subero JI; Rosenwald A; Ott G; Wiestner A; Wilson WH; Campo E; Hernández L
    Clin Cancer Res; 2013 Jun; 19(12):3121-9. PubMed ID: 23640973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'UTR mediated regulation of the cyclin D1 proto-oncogene.
    Deshpande A; Pastore A; Deshpande AJ; Zimmermann Y; Hutter G; Weinkauf M; Buske C; Hiddemann W; Dreyling M
    Cell Cycle; 2009 Nov; 8(21):3592-600. PubMed ID: 19823025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
    Rodriguez-Otero P; Román-Gómez J; Vilas-Zornoza A; José-Eneriz ES; Martín-Palanco V; Rifón J; Torres A; Calasanz MJ; Agirre X; Prosper F
    Br J Haematol; 2011 Oct; 155(1):73-83. PubMed ID: 21810092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.
    Luo Y; Li X; Dong J; Sun W
    Tumour Biol; 2016 Jun; 37(6):7749-55. PubMed ID: 26695142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LUADT1 is Upregulated in Mantle Cell Lymphoma and Modulates TRIM11 by Sponging miR-24-3p to Inhibit Cell Apoptosis.
    Dong L; Zhang H; Zan T; Han J; Xue Q; Sun Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(5):33-40. PubMed ID: 34591388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
    Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
    Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
    Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.